AzTrials
AzTrials

Periprosthetic Bone Loss in Total Knee ReplacementNCT01618149

Use Quantitative Microradiography to Predict the Periprosthetic Bone Loss in Distal Femur After Total Knee Arthroplasty

An observational study of Periprosthetic Bone Loss in Total Knee Replacement, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators hypothesized that the microarchitecture of bone influence the degree of periprosthetic bone loss after total knee arthroplasty surgery. The investigators collected the bone fragment at the distal femur while performing total knee replacement and take quantitative radiography analysis . Read more about this study

Who is it for?
Ages 50 to 70 years, women only
What is being tested?
dual energy x-ray absorptiometry
Type of treatment
Surgery or procedure
How many people
50 participants
Where
1 siteTaiwan
Study dates
Jul 2012to Jul 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 70 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: the patients who are indicated for total knee arthroplasty and are post menopausal women. The patients who had history of immune disease , fracture of the femur and end stage of renal disease will be excluded

Who may be able to join

  • severe knee osteoarthritis
  • post menopausal women

Who cannot join

  • immune disease
  • end stage of renal disease who receive dialysis
  • history of fracture at ipsilateral distal femur

Trial locations and contacts

1 site in 1 country.

Ching Chuan Jiang, professor contact

23123456 ext. 65273

ccj@ntu.edu.tw

Wei cheng Huang, resident contact

osteocheng@gmail.com

Taiwan1 site
  • National taiwan university hospital

    Taipei, Taiwan, 100

    Ching Chuan Jiang, professoir, 886223123456 ext. 65273, ccj@ntu.edu.tw

Other trials in Taiwan

About this study

Official title: Use Dual-energy X-ray Absorptiometry and Quantitative Microradiography to Predict the Periprosthetic Bone Loss in Distal Femur After Total Knee Arthroplasty

The investigators hypothesized that the microarchitecture of bone influence the degree of periprosthetic bone loss after total knee arthroplasty surgery. The investigators collected the bone fragment at the distal femur while performing total knee replacement and take quantitative radiography analysis . Before and after the surgery(6 month ,12 month) , the investigators check the BMD at identical location of the distal femur by using dual energy absorptiometry. The investigators will use linear regression to evaluate the relationship between the microarchitecture and the degree of bone loss.

Being tested
dual energy x-ray absorptiometry
Keywords
osteoarthritis, periprosthetic bone loss, dual energy x-ray absorptiometry
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • dual energy x-ray absorptiometryRadiation

    before the surgery of total knee arthroplasty and after the surgery 6 months and 12 months

Study groups in NCT01618149
Study groupRoleWhat they receive
severe knee OA who are indicated for total knee arthroplastythe woman who are indicated for TKR and are post menopausal will be recruited in this study. We will excluded the patients who had immune disease ,previous fracture of femur and end stage of renal disease
Receives: Radiation: dual energy x-ray absorptiometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in bone mineral density

    Use dual energy x-ray absorptiometry to detect to BMD at the distal femur

    Measured: before the surgery and after the sugery (6month ,12month)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2012 (estimated)
  2. Study startJul 2012
  3. Primary completionJul 2013 (estimated)
  4. Study completionJul 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01618149
Sponsor's protocol ID
201204035RIB
Status last verified
Jun 2012
First submitted
11 Jun 2012
Last updated
13 Jun 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Periprosthetic Bone Loss in Total Knee Replacement, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ching Chuan Jiang, professor (23123456 ext. 65273, ccj@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in bone mineral density (time frame: before the surgery and after the sugery (6month ,12month)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in